Correlation Between NORTHEAST UTILITIES and Teva Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NORTHEAST UTILITIES and Teva Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NORTHEAST UTILITIES and Teva Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NORTHEAST UTILITIES and Teva Pharmaceutical Industries, you can compare the effects of market volatilities on NORTHEAST UTILITIES and Teva Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NORTHEAST UTILITIES with a short position of Teva Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of NORTHEAST UTILITIES and Teva Pharmaceutical.

Diversification Opportunities for NORTHEAST UTILITIES and Teva Pharmaceutical

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between NORTHEAST and Teva is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding NORTHEAST UTILITIES and Teva Pharmaceutical Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teva Pharmaceutical and NORTHEAST UTILITIES is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NORTHEAST UTILITIES are associated (or correlated) with Teva Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teva Pharmaceutical has no effect on the direction of NORTHEAST UTILITIES i.e., NORTHEAST UTILITIES and Teva Pharmaceutical go up and down completely randomly.

Pair Corralation between NORTHEAST UTILITIES and Teva Pharmaceutical

Assuming the 90 days trading horizon NORTHEAST UTILITIES is expected to under-perform the Teva Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, NORTHEAST UTILITIES is 2.06 times less risky than Teva Pharmaceutical. The stock trades about -0.03 of its potential returns per unit of risk. The Teva Pharmaceutical Industries is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  1,035  in Teva Pharmaceutical Industries on October 4, 2024 and sell it today you would earn a total of  1,105  from holding Teva Pharmaceutical Industries or generate 106.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

NORTHEAST UTILITIES  vs.  Teva Pharmaceutical Industries

 Performance 
       Timeline  
NORTHEAST UTILITIES 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NORTHEAST UTILITIES has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's forward-looking indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Teva Pharmaceutical 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Teva Pharmaceutical Industries are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Teva Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point.

NORTHEAST UTILITIES and Teva Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NORTHEAST UTILITIES and Teva Pharmaceutical

The main advantage of trading using opposite NORTHEAST UTILITIES and Teva Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NORTHEAST UTILITIES position performs unexpectedly, Teva Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teva Pharmaceutical will offset losses from the drop in Teva Pharmaceutical's long position.
The idea behind NORTHEAST UTILITIES and Teva Pharmaceutical Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years